Top

Published in:

01-04-2008 | Original Article

Long-term results and patients’ satisfaction after transurethral ethylene vinyl alcohol (Tegress®) injections: a two-centre study

Authors: Annette Kuhn, Werner Stadlmayr, Amara Sohail, Ash Monga

Published in: International Urogynecology Journal | Issue 4/2008

Abstract

Tegress is ethylene vinyl alcohol which is non-allergenic and permanent. The aim of the study was to evaluate efficacy, feasibility and safety of transurethral Tegress® in women with urodynamic stress incontinence in a two-centre setting. Approximately 33 female patients with urodynamic stress incontinence were prospectively included in the study. Preoperatively, the patient’s history, gynaecological examination and multichannel urodynamics were performed. On follow-up, the patient was asked to use a visual analogue scale to measure her contentness and underwent uroflowmetry and a cough test. Median follow up was 51 months. About 15 women considered themselves as completely continent, and 23 (69%) were either satisfied or very satisfied. Pad test was positive in 18 (54.5%) patients, and cough test was positive in 20 (60.6%). Patients’ satisfaction did not correlate with objective dryness. Ethylene vinyl alcohol is a bulking agent with a success rate of approximately 45% after 51 months.

Keegan P, Atiemo K, Cody J, McClinton S, Pickard R (2007) Periurethral injection therapy for urinary incontinence in women.. Cochrane Database Syst Rev 18(3):CD003881

Barranger E (2000) Results of transurethral injection of silicone micro-implants for female s with intrinsic sphincter deficiency. J Urol 164(5):1619–1622PubMedCrossRef

Chrouser KL et al (2004) Carbon coated zirconium beads in beta-glucan gel and bovine glutaraldehyde cross-linked collagen injections for intrinsic sphincter deficiency: continence and satisfaction after extended follow up. J Urol 171:1152–1155PubMedCrossRef

Bent AE et al (2001) Treatment of intrinsic sphincter deficiency using autologous ear chondrocytes as a bulking agent. Neurourol Urodyn 20(2):157–165PubMedCrossRef

Haab F, Zimmern PE, Leach GE (1997) Urinary stress incontinence due to intrinsic sphincter deficiency: experience with fat and collagen periurethral injections. J Urol 157(4):1283–1286PubMedCrossRef

van Kerrebroeck P et al (2004) Efficacy and safety of a novel system (NASH/Dx copolymer via the implant device) for the treatment of SUI. Urol 64(2):276–281PubMedCrossRef

Monga AK, Robinson D, Stanton SL (1995) Periurethral collagen injections for genuine stress incontinence: a 2 year follow up. Br J Urol 75:156CrossRef

Richardson TD, Kennelly MJ, Faerber GJ (1995) Endoscopic injection of glutaraldehyde cross linked collagen for the treatment of intrinsic sphincter deficiency in women. Urology 46(3):378–381PubMedCrossRef

Pickard R et al (2003) Periurethral injection therapy for urinary stress incontinence in women. . Cochrane Database Syst Rev 2:CD003881PubMed

10.

Monga AK, Stanton SL (1997) Urodynamics—prediction, outcome and analysis of mechanism for cure of stress incontinence by periurethral collagen. Br J Obstet Gynaecol 104(2):158–162PubMed

11.

McGuire EJ, English SF (1997) Periurethral collagen injection for male and female sphincteric incontinence: indications, techniques and result. World J Urol 15(5):306–309PubMedCrossRef

12.

McGuire E, Appell RA (1994) Transurethral collagen injection for urinary incontinence. Urology 43(4):413–415PubMedCrossRef

13.

Kim YH, Kattan MW, Boone TB (1997) Correlation of urodynamic results and urethral coaptation with success after transurethral collagen injection. Urology 50(6):941–948PubMedCrossRef

14.

Gorton E, Stanton S, Monga A, Wiskind AK, Lentz GM, Bland DR (1999) Periurethral collagen injection: a long term follow up study. BJU Int 84(9):966–971PubMedCrossRef

15.

Florio F, Lauriola W, Nardella M, Strizzi V, Valone S, Trossello MP (2003) Endovascular treatment of intracranial arterio-venous malformations with Onyx embolization: preliminary experience. Radiol Med 106(5–6):512–520PubMed

16.

Rieder F, Hamer O, Gelbmann C, Schölmerich J, Gross J, Gross Feuerbach S, Herfarth H, Rogerl G (2006) Crohn’s disease of the oesophagus: treatment of an esophagobronchial fistula with the novel liquid embolic polymer “onyx”. Z Gastroenterol 44(7):599–602PubMedCrossRef

17.

Arat A, Cerkige S, Saatci I, Ozgen B (2004) Transvernous injection of Onyx for casting of the cavernous sinus for the treatment of carotid-cavernous fistula. Neuroradiology 46(12):1012–1015PubMedCrossRef

18.

Naughton CK, Myles J, Thomas AJ (2004) The use of URYX for reversible vasectomy in a rabbit model. J Androl 2(4):545–53

19.

Jackson S, Dovovan J, Brookes S et al (1996) The bristol lower urinary tract symptoms questionnaire: development and psychometric testing. BJU 77:805–812PubMedCrossRef

20.

Tamanini JT, D’Ancona CA, Netto NR (2006) Macroplastique implantation system for female stress urinary incontinence: long-term follow-up. J Endorurol 20(12):1082–1086CrossRef

21.

Abdala N, Levitin A, Dawson A, Maffra R, Munoz-Ramirez H, Godec K, Dolmatch BL (2001) Use of ethylenevinylalcohol for tubal sterilization by selective catheterization in rabbits. J Vasc Inter Radiology 12:979–984CrossRef

22.

Schneider T, Sperling H, Rossi R Schmidt S, Rübben H (2006) Do early injections of bulking agents following radical prostatectomy improve early continence? World J Urol 23:338–342CrossRef

23.

Dmochowski RR (2005) Tegress urethral implant phase III clinical experience uniqueness Rev Urol 7(suppl 1):S22–S26; presented at the ICS 2005, Paris

24.

Hurtado E, McCrery R, Appell R (2007) The safety and efficacy of ethylene vinyl alcohol copolymer as an intra-urethral bulking agent in women with intrinsic urethral deficiency. Int Urogynecol J 18:869–873CrossRef

25.

Ereksen EA, Sung VW, Rardin CR, Myers DC (2007) Ethylene vinyl alcohol copolymer erosions after use as urethral bulking agent. Obstet Gynecol 109:490–492

26.

Ward KL, Hilton P (2004) A prospective multicenter randomized trial of tension free vaginal tape and colposuspension for primary urodynamic stress incontinence: two year follow up. Am J Obstet Gynecol 190(2):324–331PubMedCrossRef

27.

Ulmsten U, Henriksson L, Johnson P, Varhos G (1996) An ambulatory surgical procedure under local anaesthesia for treatment of female urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 7(2):81–85PubMedCrossRef

28.

Reid FM, Smoth AR, Dunn G (2007) Which questionnaire? A psychometric evaluation of three patient-based outcome measures used to assess surgery for stress urinary incontinence. Neurourol Urodyn 26(1):123–128PubMedCrossRef

Title: Long-term results and patients’ satisfaction after transurethral ethylene vinyl alcohol (Tegress®) injections: a two-centre study
Authors: Annette Kuhn
Werner Stadlmayr
Amara Sohail
Ash Monga
Publication date: 01-04-2008
Publisher: Springer-Verlag
Published in: International Urogynecology Journal / Issue 4/2008
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-007-0479-5

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Long-term results and patients’ satisfaction after transurethral ethylene vinyl alcohol (Tegress®) injections: a two-centre study

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2008

A randomized comparison of polypropylene mesh surgery with site-specific surgery in the treatment of cystocoele

Effect of micturition on clitoris and cavernosus muscles: an electromyographic study

Combined estrogen and ghrelin administration restores number of blood vessels and collagen type I/III ratio in the urethral and anal canal submucosa of old ovariectomized rats

Planned cesarean section versus planned vaginal delivery: comparison of lower urinary tract symptoms

Ageing of the female pelvic floor: towards treatment a la carte of the “geripause”

Sequential hydrodistension and intravesical instillation of hyaluronic acid under general anaesthesia for treatment of refractory interstitial cystitis: a pilot study